Saturation biopsies for prostate cancer: Current uses and future prospects

Nature Reviews Urology

Volumn 6, Issue 12, 2009, Pages 645-652

  Delongchamps, Nicolas B ^a   Haas, Gabriel P ^b  

^a Cochin Hospital ^*  (France)

^b SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADVANCED CANCER; BRACHYTHERAPY; CANCER GRADING; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER STAGING; CANCER SURGERY; COLOR ULTRASOUND FLOWMETRY; COMORBIDITY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; DIFFUSION WEIGHTED IMAGING; ECHOGRAPHY; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; NEEDLE BIOPSY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARENT COUNSELING; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; REVIEW; SENSITIVITY AND SPECIFICITY; THREE DIMENSIONAL IMAGING;

BIOPSY; FORECASTING; HUMANS; MALE; NEOPLASM STAGING; PROSTATE; PROSTATIC NEOPLASMS;

EID: 75149116090     PISSN: 17594812     EISSN: 17594820     Source Type: Journal    
DOI: 10.1038/nrurol.2009.213     Document Type: Review

References (58)

1. Eichler, K. et al. Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review. J. Urol. 175, 1605-1612 (2006).
2. Pryor, M. B. & Schellhammer, P. F. The pursuit of prostate cancer in patients with a rising prostate-specific antigen and multiple negative transrectal ultrasound-guided prostate biopsies. Clin. Prostate Cancer 1, 172-176 (2002).
3. Borboroglu, P. G., Comer, S. W., Riffenburgh, R. H. & Amling, C. L. Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies. J. Urol. 163, 158-162 (2000).
4. Haas, G. P. et al. Needle biopsies on autopsy prostates: sensitivity of cancer detection based on true prevalence. J. Natl Cancer Inst. 99, 1484-1489 (2007).
5. Delongchamps, N. B., de la Roza, G., Jones, R., Jumbelic, M. & Haas, G. P. Saturation biopsies on autopsied prostates for detecting and characterizing prostate cancer. BJU Int. 103, 49-54 (2009).
6. Master, V. A., Chi, T., Simko, J. P., Weinberg, v. & Carroll, P. R. The independent impact of extended pattern biopsy on prostate cancer stage migration. J. Urol. 174, 1789-1793 (2005).
7. Ung, J. O., Richie, J. P., Chen, M. H., Renshaw, A. A. & D'Amico, A. v. Evolution of the presentation and pathologic and biochemical outcomes after radical prostatectomy for patients with clinically localized prostate cancer diagnosed during the PSA era. Urology 60, 458 (2002).
8. Galper, S. L. et al. Evidence to support a continued stage migration and decrease in prostate cancer specific mortality. J. Urol. 175, 907-912 (2006).
9. Stamey, T. A. et al. Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer. Cancer 71, 933-938 (1993).
10. Epstein, J. I., Walsh, P. C., Carmichael, M. & Brendler, C. B. Pathologic and clinical findings to predict tumor extent of nonpalpable (T1c) prostate cancer. JAMA 271, 368-374 (1994).
11. Jones, J. S. et al. Saturation technique does not improve cancer detection as an initial prostate biopsy strategy. J. Urol. 175, 485-488 (2006).
12. Descazeaud, A. et al. Saturation biopsy protocol enhances prediction of pT3 and surgical margin status on prostatectomy specimen. World J. Urol. 24, 676-680 (2006).
13. Lane, B. R. et al. Saturation technique does not decrease cancer detection during followup after initial prostate biopsy. J. Urol. 179, 1746-1750 (2008).
14. Campos-Fernandes, J. L. et al. Prostate cancer detection rate in patients with repeated extended 21-sample needle biopsy. Eur. Urol. 55, 600-609 (2009).
15. Patel, A. R., Jones, J. S., Rabets, J., DeOreo, G. & Zippe, C. D. Parasagittal biopsies add minimal information in repeat saturation prostate biopsy. Urology 63, 87-89 (2004).
16. Ficarra, V. et al. The potential impact of prostate volume in the planning of optimal number of cores in the systematic transperineal prostate biopsy. Eur. Urol. 48, 932-937 (2005).
17. Igel, T. C. et al. Systematic transperineal ultrasound guided template biopsy of the prostate in patients at high risk. J. Urol. 165, 1575-1579 (2001).
18. Rabets, J. C., Jones, J. S., Patel, A. & Zippe, C. D. Prostate cancer detection with office based saturation biopsy in a repeat biopsy population. J. Urol. 172, 94-97 (2004).
19. Bott, S. R. J. et al. Extensive transperineal template biopsies of prostate: modified technique and results. Urology 68, 1037-1041 (2006).
20. Jones, J. S. Prostate cancer: are we overdiagnosing- or under-thinking? Eur. Urol. 53, 10-12 (2008).
21. Ravery, V. et al. Percentage of cancer on biopsy cores accurately predicts extracapsular extension and biochemical relapse after radical prostatectomy for T1-T2 prostate cancer. Eur. Urol. 37, 449-455 (2000).
22. Algaba, F. et al. Prognostic parameters other than Gleason score for the daily evaluation of prostate cancer in needle biopsy. Eur. Urol. 48, 566-571 (2005).
23. Montironi, R., vela-Navarrete, R., Lopez- Beltran, A., Mazzucchelli, R. & Bono, A. 2005 update on pathology of prostate biopsies with cancer. Eur. Urol. 49, 441-447 (2006). (Pubitemid 43259550)
24. Grossklaus, D. J. et al. Prediction of tumor volume and pathological state in radical prostatectomy specimens is not improved by taking more prostate needle-biopsy cores. BJU Int. 88, 722-726 (2001).
25. D'Amico, A. V. et al. Pathologic findings and prostate specific antigen outcome after radical prostatectomy for patients diagnosed on the basis of a single microscopic focus of prostate carcinoma with a Gleason score 7. Cancer 89, 1810-1817 (2000).
26. Mian, B. M. et al. Role of prostate biopsy schemes in accurate prediction of Gleason scores. Urology 67, 379-383 (2006).
27. Furuya, Y. et al. Preoperative parameters to predict tumor volume in Japanese patients with nonpalpable prostate cancer. Int. J. Clin. Oncol. 7, 109-113 (2002).
28. Carter, H. B., Sauvageot, J., Walsh, P. C. & Epstein, J. I. Prospective evaluation of men with T1c adenocarcinoma of the prostate. J. Urol. 157, 2206-2209 (1997).
29. Noguchi, M., Stamey, T. A., McNeal, J. E. & Yemoto, C. M. Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer. J. Urol. 166, 104-109 (2001).
30. Anast, J. W., Andriole, G. L., Bismar, T. A., Yan, Y. & Humphrey, P. A. Relating biopsy and clinical variables to radical prostatectomy findings: can insignificant and advanced prostate cancer be predicted in a screening population? Urology 64, 544-550 (2004).
31. Allan, R. W., Sanderson, H. & Epstein, J. I. Correlation of minute (0.5 mm or less) focus of prostate adenocarcinoma on needle biopsy with radical prostatectomy specimen: role of prostate specific antigen density. J. Urol. 170, 370-372 (2003).
32. Boccon-Gibod, L. M., Dumonceau, O., Toublanc, M., Ravery, v. & Boccon-Gibod, L. A. Micro-focal cancer: a comparison of biopsy and radical prostatectomy specimen features. Eur. Urol. 48, 895-899 (2005).
33. Wise, A. M., Stamey, T. A., McNeal, J. E. & Claytoin, J. L. Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens. Urology 60, 264 (2002).
34. Boccon-Gibod, L. M., Delongchamps, N. B., Toublanc, M., Boccon-Gibod, L. A. & Ravery, V. Prostate saturation biopsy in the reevaluation of microfocal prostate cancer. J. Urol. 176, 961-963 (2006).
35. Epstein, J. I., Sanderson, H., Carter, H. B. & Scharfstein, D. O. Utility of saturation biopsy to predict insignificant cancer at radical prostatectomy. Urology 66, 356-360 (2005).
36. Delongchamps, N. B. et al. Diagnostic accuracy of extended biopsies for the staging of microfocal prostate cancers in autopsy specimen. Prostate Cancer Prostatic Dis. 12, 137-142 (2009).
37. Vis, A. N. et al. Detection of prostate cancer: a comparative study of the diagnostic efficacy of sextant transrectal versus sextant transperineal biopsy. Urology 56, 617-621 (2000).
38. Kawakami, S. et al. Optimal sampling sites for repeat prostate biopsy: a recursive partitioning analysis of three-dimensional 26-core systematic biopsy. Eur. Urol. 51, 675-683 (2007).
39. Scattoni, V. et al. Extended and saturation prostatic biopsy in the diagnosis and characterisation of prostate cancer: a critical analysis of the literature. Eur. Urol. 52, 1309-1322 (2007).
40. Emiliozzi, P. et al. Best approach for prostate cancer detection: a prospective study on transperineal versus transrectal six-core prostate biopsy. Urology 6, 961-966 (2003).
41. Kawakami, S. et al. Direct comparison between transrectal and transperineal extended prostate biopsy for the detection of cancer. Int. J. Urol. 14, 719-724 (2007).
42. Onik, G. & Barzell, W. Transperineal 3D mapping biopsy of the prostate: an essential tool in selecting patients for focal prostate cancer therapy. Urology 26, 506-510 (2008).
43. Andriole, G. L. et al. Is there a better way to biopsy the prostate? Prospects for a novel transrectal systematic biopsy approach. Urology 70, 22-26 (2007).
44. Megwalu, I. I. et al. Evaluation of a novel precision template-guided biopsy system for detecting prostate cancer. BJU Int. 102, 546-550 (2008).
45. Onur, R., Littrup, P. J., Pontes, J. E. & Bianco, F. J. Jr. Contemporary impact of transrectal ultrasound lesions for prostate cancer detection. J. Urol. 172, 512-514 (2004).
46. Pallwein, L. et al. value of contrast-enhanced ultrasound and elastography in imaging of prostate cancer. Curr. Opin. Urol. 17, 39-47 (2007). (Pubitemid 44901089)
47. Amiel, G. E. & Slawin, K. M. Newer modalities of ultrasound imaging and treatment of the prostate. Urol. Clin. North Am. 33, 329-337 (2006).
48. Halpern, E. J. et al. Detection of prostate carcinoma with contrast- enhanced sonography using intermittent harmonic imaging. Cancer 104, 2373-2383 (2005).
49. Wefer, A. E. et al. Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology. J. Urol. 164, 400-404 (2000).
50. Stefanou, D. et al. Expression of vascular endothelial growth factor (vEGF) and association with microvessel density in benign prostatic hyperplasia and prostate cancer. In Vivo 18, 155-160 (2004). (Pubitemid 38488998)
51. Mullerad, M. et al. Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer. J. Urol. 174, 2158-2163 (2005).
52. Kozlowski, P. et al. Combined diffusion weighted and dynamic contrast-enhanced MRI for prostate cancer diagnosis: correlation with biopsy and histopathology. J. Magn. Reson. Imaging 24, 108-113 (2006).
53. Borboroglu, P. G., Comer, S. W., Riffenburgh, R. H. & Amling, C. L. Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies. J. Urol. 163, 158-162 (2000).
54. Stewart, C. S., Leibovich, B. C., Weaver, A. L. & Lieber, M. M. Prostate cancer diagnosis using saturation biopsy technique after previous negative sextant biopsies. J. Urol. 166, 86-92 (2001).
55. Fleshner, N. & Klotz, L. Role of "saturation biopsy" in the detection of prostate cancer among difficult diagnostic cases. Urology 60, 93-97 (2002).
56. Pinkstaff, D. M. et al. Systematic transperineal ultrasound guided template biopsy of the prostate: three-year experience. Urology 65, 735-739 (2005).
57. Moran, B. J., Braccioforte, M. H. & Conterato, D. J. Re-biopsy of the prostate using a stereotactic transperineal technique. J. Urol. 176, 1376-1381 (2006).
58. Merrick, G. S. et al. Prostate cancer distribution in patients diagnosed by transperineal templateguided saturation biopsy. Eur. Urol. 52, 715-723 (2007).